Nobel Conference on Biofilm formation, its clinical impact and potential treatment

This interdisciplinary Nobel conference ‘Biofilm formation, its clinical impact and potential treatment’ aims to cover recent progress in the research area of biofilm formation. The conference will gather leading researchers from the pre-clinical and clinical side who collectively cover the broad spectrum of biofilm research from the molecular analysis of basic phenomena over the clinical impact to approaches to prevent biofilm formation. The conference will provide a forum to stimulate the exchange of ideas and cross-disciplinary discussion to find novel ways to treat infections caused by biofilm-forming bacteria in order to promote research progress on this important health problem. The conference will report on important fundamental discoveries made in the biofilm research area and will describe the impact of biofilm formation on treatment failure, the resistance phenotype of biofilm forming cells, the interaction of biofilm bacteria with the immune system, bioinformatics of biofilm formation and applications of biofilm bacteria leading to health benefit. In addition, various strategies to treat biofilm infections will be discussed.
+ show speakers and program
Preliminary program

Scientific program
• The clinical problem – persistent infections by biofilm-forming microorganisms
• Device related infections
• Soft tissue infections
• Biofilm diagnostics
• Biofilm –Basics- Regulation
• Biofilm –Basics- Structure
• Bioinformatics of biofilm formation
• Molecular basis of foreign body infections
• Biofilms and the immune system
• The resistance phenotype
• Prevention of biofilm formation
• Biofilms and cancer

Poster sessions and Round table discussion
‘Health and economical consequences of biofilm infections, future treatment strategies and research needs’
Coordinator: Lars Nyman

Confirmed speakers (as of February 19, 2013)
Fredrik Almqvist, Umeå University, Sweden
Annelie Brauner, MTC Karolinska Institutet, Sweden
Henk J Busscher, University Medical Center and University of Groningen, The Netherlands
James J Collins, Boston University, USA
Michael Galperin, NIH, Bethesda, USA
Jean-Marc Ghigo, Institut Pasteur, Paris, France
Michael Givskov, University of Copenhagen, Denmark
Angelika Gründling, Imperial College London, Great Britain
Robert Hancock, University of British Columbia, Canada
Niels Hoiby, University Hospital of Copenhagen, Denmark
Scott Hultgren, Washington University in Saint Louis, USA
Susanne Häussler, Medical School of Hannover, Germany
Urs Jenal, University of Basel, Switzerland
Staffan Kjelleberg, School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia and Singapore Center of on Environmental Life Sciences, Nanyang Technological University, Singapore
Ken Nealson, University of Southern California, USA
Zhao-Xun Liang, NUS Singapore, Singapore
Kim Lewis, Northeastern University Boston, USA
Richard Losick, Harvard University, USA
Aaron P. Mitchell, Carnegie Mellon University, USA
Sören Molin, Technical University of Denmark
Per H. Nielsen, Aalborg University, Denmark
Michael Otto, NIH, Bethesda, USA
Matthew R. Parsek, University of Washington, Seattle, USA
Daniel A. Portnoy, University of California at Berkeley, USA
Holger Sondermann, Cornell University, USA
David J. Stickler, Cardiff University, Great Britain
Richard A. Strugnell, The University of Melbourne, Australia
Russell E. Vance, University of California at Berkeley, USA
Gerhard Wagner, Uppsala University, Sweden
Siegfried Weiss, Helmholtz Center for Infection Research, Germany
Fitnat Yildiz, University of California Santa Cruz, USA
Werner Zimmerli, Basel University Medical Clinic, Switzerland

28 Aug - 30 Aug 2013
meeting website